Is there a rationale for high-dose chemotherapy as first line treatment of advanced Hodgkin's disease? German Hodgkin's Lymphoma Study Group (GHSG).

Source:http://linkedlifedata.com/resource/pubmed/id/7767261

Download in:

View as

General Info

PMID
7767261